Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD

被引:20
|
作者
Bioulac, Stephanie [1 ,2 ,3 ]
Purper-Ouakil, Diane [4 ]
Ross, Tomas [5 ]
Blasco-Fontecilla, Hilario [6 ,7 ]
Prats, Marie [8 ]
Mayaud, Louis [8 ]
Brandeis, Daniel [9 ,10 ,11 ]
机构
[1] CHU Pellegrin, Clin Sommeil, F-33076 Bordeaux, France
[2] Univ Bordeaux, Sommeil Addict & Neuropsychiat, USR 3413, F-33000 Bordeaux, France
[3] CNRS, SANPSY, USR 3413, F-33000 Bordeaux, France
[4] CHU Montpellier St Eloi Hosp, Unit Child & Adolescent Psychiat MPEA1, Montpellier, France
[5] Univ Geneva, Dept Neurosci, Lab Neurol & Imaging Cognit, Geneva, Switzerland
[6] Puerta de Hierro Univ Hosp, Segovia de Arana Hlth Res Inst IDIPHISA, Dept Psychiat, Ave Manuel Falla S-N, Madrid, Spain
[7] Univ Autonoma Madrid, Madrid, Spain
[8] Mensia Technol, 130 Rue Lourmel, F-75015 Paris, France
[9] Univ Zurich, Zurich, Switzerland
[10] Swiss Fed Inst Technol, Neurosci Ctr Zurich, Zurich, Switzerland
[11] Heidelberg Univ, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Med Fac Mannheim, Mannheim, Germany
关键词
Attention deficit hyperactivity disorder; Neurofeedback; Methylphenidate; Clinical trial; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; DIFFICULTIES QUESTIONNAIRE; VALIDITY; SCALE; EEG; BRAIN; CONSISTENCY; ANNOTATION; VALIDATION;
D O I
10.1186/s12888-019-2218-0
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
BackgroundNeurofeedback (NF) has gained increasing interest among non-pharmacological treatments for Attention Deficit Hyperactivity Disorder (ADHD). NF training aims to enhance self-regulation of brain activities. The goal of the NEWROFEED study is to assess the efficacy of a new personalized NF training device, using two different protocols according to each child's electroencephalographic pattern, and designed for use at home. This study is a non-inferiority trial comparing NF to methylphenidate.MethodsThe study is a prospective, multicentre, randomized, reference drug-controlled trial. One hundred seventy-nine children with ADHD, aged 7 to 13years will be recruited in 13 clinical centres from 5 European countries. Subjects will be randomized to two groups: NF group (Neurofeedback Training Group) and MPH group (Methylphenidate group). Outcome measures include clinicians, parents and teachers' assessments, attention measures and quantitative EEG (qEEG). Patients undergo eight visits over a three-month period: pre-inclusion visit, inclusion visit, 4 discovery (NF group) or titration visits (MPH group), an intermediate and a final visit. Patients will be randomized to either the MPH or NF group. Children in the NF group will undergo either an SMR or a Theta/Beta training protocol according to their baselineTheta/Beta Ratio obtained from the qEEG.DiscussionThis is the first non-inferiority study between a personalized NF device and pharmacological treatment. Innovative aspects of Mensia Koala (TM) include the personalization of the training protocol according to initial qEEG characteristics (SMR or Theta/Beta training protocols) and an improved accessibility of NF due to the opportunity to train at home with monitoring by the clinician through a dedicated web portal.Trial registrationNCT02778360. Date registration (retrospectively registered): 5-12-2016. Registered May 19, 2016
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD
    Stéphanie Bioulac
    Diane Purper-Ouakil
    Tomas Ros
    Hilario Blasco-Fontecilla
    Marie Prats
    Louis Mayaud
    Daniel Brandeis
    BMC Psychiatry, 19
  • [2] Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial
    Purper-Ouakil, Diane
    Blasco-Fontecilla, Hilario
    Ros, Tomas
    Acquaviva, Eric
    Banaschewski, Tobias
    Baumeister, Sarah
    Bousquet, Elisa
    Bussalb, Aurore
    Delhaye, Marie
    Delorme, Richard
    Drechsler, Renate
    Goujon, Allison
    Hage, Alexander
    Kaiser, Anna
    Mayaud, Louis
    Mechler, Konstantin
    Menache, Caroline
    Revol, Olivier
    Tagwerker, Friederike
    Walitza, Susanne
    Werling, Anna Maria
    Bioulac, Stephanie
    Brandeis, Daniel
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2022, 63 (02) : 187 - 198
  • [3] Efficacy and safety of OROSO methylphenidate in adults with ADHD the long-acting methylphenidate in adult ADHD (lamda) trial
    Medori, R.
    Kooij, S.
    Ramos-Quiroga, J. A.
    Buitelaar, J.
    Lee, E.
    Casas, M.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (07) : XCII - XCIII
  • [4] Non-inferiority efficacy trial of risperidone long-acting injection vs. olanzapine tablets
    Rabinowitz, J
    Khan, A
    Augustyns, I
    Ingham, M
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 94 - 95
  • [5] Heterogeneity in ADHD children's response to two long-acting methylphenidate formulations
    Sonuge-Barke, E. J. S.
    Swanson, J.
    Hatch, S.
    Van Lier, P.
    Vandenberghe, M.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (07) : LXXXIX - LXXXIX
  • [6] Effectiveness and compatibility of OROS®-methylphenidate for adult with ADHS -: The long-acting methylphenidate in adult ADHD (LAMDA) trial
    Gerwe, Martin
    Philipsen, A.
    Roesler, M.
    Sobanski, E.
    Schaeuble, B.
    Medori, R.
    Trott, G. -E.
    NERVENARZT, 2007, 78 : 208 - 209
  • [7] Efficacy and safety of OROS® methylpheniclate in adults with ADHD:: the long-acting methylphenidate in adult ADHD (LAMDA) trial
    Roesler, M.
    Trott, G. E.
    Philipsen, A.
    Gerwe, M.
    Lee, E.
    Medori, R.
    Schauble, B.
    PHARMACOPSYCHIATRY, 2007, 40 (05) : 248 - 248
  • [8] Open-label extension trial of the safety and tolerability of OROSO methylphenidate in adults with ADHD - the long-acting methylphenidate in adult ADHD (lamda) trial
    Kooij, S.
    Medori, R.
    Buitelaar, J.
    Ramos-Quiroga, J. A.
    Lee, E.
    Casas, M.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (07) : XCIII - XCIII
  • [9] Offene extensions-study for compatibility of OROS-methylphenidate for adult with ADHD -: The long-acting methylphenidate in adult ADHD (LAMDA) trial
    Gerwe, Martin
    Roesler, M.
    Trott, G. -E.
    Philipsen, A.
    Sobanski, E.
    Medori, R.
    Schaeuble, B.
    NERVENARZT, 2007, 78 : 208 - 208
  • [10] Comparison of long-acting methylphenidate formulations in children with ADHD: Pooled analysis of 2 randomized, placebo-controlled studies
    Silva, RR
    Brams, M
    Childress, A
    Lopez, FA
    Pestreich, L
    Muniz, R
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2004, 14 (04) : 514 - 515